Category Archives: Pr Newswire

Nature’s Capital: Why Asia’s Governments Are Turning to Nature-Based Solutions

SINGAPORE, March 17, 2026 /PRNewswire/ — Lester Chan, CEO & Chairman, The GrowHub Limited (Nasdaq: TGHL) explains how forests, mangroves, and peatlands are reshaping climate strategy The first wave of carbon markets was about avoidance. The second wave is about removal. The third—gathering momentum now—is about nature itself. Across Asia, governments are recognising a fundamental […]

Starlight Investments Announces the Closing of Canadian Multi-family Growth Fund IV

Largest Fund Raised to Date by Starlight, Enabling the Acquisition of over 10,000 Rental Suites TORONTO, March 17, 2026 /PRNewswire/ — Starlight Investments (“Starlight”), a leading global real estate investment and asset management firm, today announced the successful closing of Starlight Canadian Residential Growth Fund IV (“Growth Fund IV”), the fourth fund in the firm’s […]

Monoova Launches an FX Hub to Bring Real-Time Collection Infrastructure to Global Money Movement

New platform unifies collections, currency conversion, funding and settlement, enabling same-day global payments SYDNEY, March 17, 2026 /PRNewswire/ — Today, Monoova announced the launch of its FX Hub, a new capability bringing domestic collections, foreign exchange conversion, funding, and settlement into a single automated flow. Global payments are often slowed by fragmented banking relationships, multiple […]

Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results

DALLAS, March 17, 2026 /PRNewswire/ — Cango Inc. (NYSE: CANG), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Financial and Operational Highlights Total revenues were $688.1 million for the full year, […]

Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session

MONTREAL and CHARLOTTE, N.C., March 16, 2026 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that a moderated poster presentation titled “Minimal Blood Pressure Effects of Intranasal Etripamil in Trials for Paroxysmal Supraventricular Tachycardia (PSVT)” will be featured at the […]

Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation

RESEARCH TRIANGLE PARK, N.C., March 16, 2026 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the litigation between them regarding Cipla’s application to FDA for approval to market a generic version of […]

Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced an amendment to its existing convertible note with Avondale Capital, LLC (the “Existing Note”) and the issuance of a new non-convertible, unsecured […]

Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

Espoo, Finland, March 16, 2026: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, announces that its Chief Scientific Officer, Henri Huttunen, will be delivering an oral presentation at the 20th International Conference on Alzheimer’s & Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026), held in Denmark […]

George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement

Arrotex gains exclusive rights in Australia and New Zealand to innovative single pill combination of three hypertension medicines, including two doses that are lower than those currently available in single pill combinations GMRx2 is designed to deliver blood pressure-lowering benefits of triple combination therapy early in the treatment pathway, with an established safety profile George […]

Ant International Becomes Official Sponsor of The Argentine National Football Team

Through the partnership, Ant International secures comprehensive marketing rights of the Argentine Football Association (AFA) and world-class players of the Argentine National Football Team to launch strategic activations across its brand portfolio, including Alipay+, Antom, Bettr and WorldFirst BUENOS AIRES, Argentina and SINGAPORE, March 16, 2026 /PRNewswire/ — Ant International, a leading global payment, digitisation, […]